Status:
COMPLETED
Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity
Lead Sponsor:
Royan Institute
Conditions:
In Vitro Fertilization
Eligibility:
FEMALE
20-37 years
Phase:
PHASE3
Brief Summary
This study is a prospective randomized clinical trial to compare the efficacy of the urinary and recombinant hCG on oocyte quality for ovulation induction in women undergoing IVF/ICSI.
Detailed Description
The study population comprised of all infertile patients aged 20-37 years which underwent of in-vitro fertilization in royan institute, Tehran Iran. In this study all patients were treated with a lon...
Eligibility Criteria
Inclusion
- Indication for IVF/ICSI and Long Protocol ovarian stimulation
- Age 20-37
- Body mass index (BMI) ≤ 30 kg/m2
- Regular menstrual cycles of 25-35 days
- Tubal or male factor
- Existence of both ovary and normal uterine cavity
- Basal FSH≥10
- Physical health
Exclusion
- Poly Cystic Ovarian Syndrome patients
- Contraindications of gonadotropins administration
- Poor response to ovulation induction in recent cycle
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01507376
Start Date
October 1 2010
End Date
June 1 2013
Last Update
April 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royan Institute
Tehran, Iran